Nuo Therapeutics, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Nuo Therapeutics, Inc. (AURX) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $449.32 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $449.32K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $263.83K.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $548.95K.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $514.80K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations |
|---|---|
| 2026-06-30 | $449.32K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $263.83K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $548.95K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $514.80K 10-Q · filed 2025-10-30 |
| 2025-06-30 | $316.35K 10-Q · filed 2026-08-14 |
| 2025-03-31 | $55.66K 10-Q · filed 2026-05-14 |
| 2024-12-31 | $283.71K 10-Q · filed 2026-08-14 |
| 2024-09-30 | $683.84K 10-Q · filed 2025-10-30 |
| 2024-06-30 | $473.04K 10-Q · filed 2025-07-31 |
| 2024-03-31 | $366.23K 10-Q · filed 2025-04-30 |
| 2023-12-31 | $928.68K 10-K · filed 2026-03-30 |
| 2023-09-30 | $637.59K 10-Q · filed 2024-11-12 |
| 2023-06-30 | $399.37K 10-Q · filed 2024-08-12 |
| 2023-03-31 | $1.31M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $2.11M 10-K · filed 2025-04-01 |
| 2022-09-30 | $2.93M 10-Q · filed 2022-11-04 |
| 2022-06-30 | $3.44M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $665.39K 10-Q · filed 2023-05-15 |
| 2021-12-31 | $1.41M 10-K · filed 2024-04-19 |
| 2021-09-30 | $148.43K 10-Q · filed 2022-11-04 |
| 2021-06-30 | $151.59K 10-Q/A · filed 2022-08-10 |
| 2021-03-31 | $157.26K 10-Q · filed 2022-05-16 |
| 2020-12-31 | $161.43K 10-K · filed 2023-04-17 |
| 2020-09-30 | $0.00 10-Q · filed 2022-11-04 |
| 2020-06-30 | $13.00 10-K · filed 2022-04-15 |
| 2020-03-31 | $11.21K 10-K · filed 2022-04-15 |
| 2019-12-31 | $20.25K 10-Q · filed 2022-11-04 |
| 2019-09-30 | $17.33K 10-Q · filed 2020-01-31 |
| 2019-06-30 | $9.04K 10-Q · filed 2019-08-19 |
| 2019-03-31 | $185.31K 10-Q · filed 2019-05-20 |
| 2018-12-31 | $636.93K 10-K · filed 2022-04-15 |
| 2018-09-30 | $250.17K 10-Q · filed 2020-01-31 |
| 2018-06-30 | $373.29K 10-Q · filed 2019-08-19 |
| 2018-03-31 | $146.94K 10-Q · filed 2019-05-20 |
| 2017-12-31 | $693.51K 10-Q · filed 2020-01-31 |
| 2017-09-30 | $1.97M 10-Q · filed 2018-11-16 |
| 2017-06-30 | $381.03K 10-Q · filed 2018-08-13 |
| 2017-03-31 | $1.39M 10-Q · filed 2018-05-14 |
| 2016-12-31 | $2.67M 10-K · filed 2019-04-16 |